Table 4 Nonhaematological toxicities

From: Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients

 

Total=61

 

Grade 2 – No. (%)

Grade 3 – No. (%)

Grade 4 – No. (%)

Diarrhoea

12 (20)

7 (11)

0 (0)

Mucositis

7 (11)

2 (3)

0 (0)

Vomiting

7 (11)

2 (3)

0 (0)

Neurological

20 (33)

13 (21)

0 (0)

Fatigue

3 (5)

2 (3)

0 (0)

Nausea

6 (10)

2 (3)

0 (0)

Back to article page